E-LIB Suche - Ergebnisse für: Tolley, Keith

1

Society for Immunotherapy of Cancer (SITC) clinical practic..:

Pavlick, Anna C ; Ariyan, Charlotte E ; Buchbinder, Elizabeth I...
Journal for ImmunoTherapy of Cancer. 11 (2023) 10 - p. e006947 , 2023

Link: https://doi.org/10.1136/..

2

Model parameters influencing the cost-effectiveness of sacu..:

Proudfoot, Clare ; Gautam, Raju ; Cristino, Joaquim...
The European Journal of Health Economics. 24 (2022) 3 - p. 453-467 , 2022

Link: https://doi.org/10.1007/..

3

Investigation of Health-Related Quality of Life Outcomes in..:

Casadei, Gianluigi ; Tolley, Keith ; Bettio, Monica...
SN Comprehensive Clinical Medicine. 2 (2020) 9 - p. 1579-1584 , 2020

Link: https://doi.org/10.1007/..

4

Comparative Effectiveness of Adding Alogliptin to Metformin..:

Kay, Stephen ; Strickson, Amanda ; Puelles, Jorge...
Diabetes Therapy. 8 (2017) 2 - p. 251-273 , 2017

Link: https://doi.org/10.1007/..

5

Unlocking the potential of established products: toward new..:

Nayroles, Gabrielle ; Frybourg, Sandrine ; Gabriel, Sylvie...
Journal of Market Access & Health Policy. 5 (2017) 1 - p. 1298190 , 2017

Link: https://doi.org/10.1080/..

6

Pharmacoeconomic evaluations in the treatment of actinic ke..:

Tolley, Keith ; Argenziano, Giuseppe ; Calzavara-Pinton, Pier Giacomo..
International Journal of Immunopathology and Pharmacology. 30 (2017) 2 - p. 178-181 , 2017

Link: https://doi.org/10.1177/..

7

OP19 Unlocking The Potential Of Established Products: Need ..:

Nayroles, Gabrielle ; Gabriel, Sylvie ; Toumi, Mondher...
International Journal of Technology Assessment in Health Care. 33 (2017) S1 - p. 9-9 , 2017

Link: https://doi.org/10.1017/..

8

8th European Conference on Rare Diseases & Orphan Products ..:

Schlander, Michael ; Holm, Søren ; Nord, Erik...
Orphanet Journal of Rare Diseases. 11 (2016) S1 - p. , 2016

Link: https://doi.org/10.1186/..

9

A cost-utility analysis of ingenol mebutate gel for the tre..:

Tolley, Keith ; Kemmett, Danny ; Thybo, Signe..
The European Journal of Health Economics. 17 (2016) 3 - p. 287-304 , 2016

Link: https://www.jstor.org/st..

10

Determining the value of medical technologies to treat ultr..:

Schlander, Michael ; Garattini, Silvio ; Kolominsky-Rabas, Peter...
Journal of Market Access & Health Policy. 4 (2016) 1 - p. 33039 , 2016

Link: https://doi.org/10.3402/..

11

A cost-utility analysis of ingenol mebutate gel for the tre..:

Tolley, Keith ; Kemmett, Danny ; Thybo, Signe..
The European Journal of Health Economics. 17 (2015) 3 - p. 287-304 , 2015

Link: https://doi.org/10.1007/..

12

Cost effectiveness of lanthanum carbonate in chronic kidney..:

Gros, Blanca ; Galán, Antonio ; González-Parra, Emilio...
Health Economics Review. 5 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

13

A Network Meta-Analysis of Efficacy and Evaluation of Safet..:

Tolley, Keith ; Hutchinson, Michael ; You, Xiaojun...
PLOS ONE. 10 (2015) 6 - p. e0127960 , 2015

Link: https://doi.org/10.1371/..

14

Reimbursement of Targeted Cancer Therapies Within 3 Differe..:

Mihajlović, Jovan ; Dolk, Christiaan ; Tolley, Keith..
Clinical Therapeutics. 37 (2015) 2 - p. 474-480 , 2015

Link: https://doi.org/10.1016/..

15

Systematic Literature Review and Network Meta-Analysis of P..:

Tolley, Keith ; Hutchinson, Michael ; Pachner, Andrew...
Neurology. 82 (2014) 10_supplement - p. , 2014

Link: https://doi.org/10.1212/..